Detalles de la búsqueda
1.
Type 2 diabetes subgroups and response to glucose-lowering therapy: Results from the EDICT and Qatar studies.
Diabetes Obes Metab
; 24(9): 1810-1818, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35581905
2.
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT).
Diabetes Obes Metab
; 24(5): 899-907, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35014145
3.
Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study.
Diabetes Obes Metab
; 23(7): 1631-1639, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852204
4.
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT.
Diabetes Care
; 44(2): 433-439, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33273042
Resultados
1 -
4
de 4
1
Próxima >
>>